(Q45341636)

English

WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015.

scientific article published on 19 June 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015 (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

World Health Organization

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

Birgitte Giersing

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

David C Kaslow

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Vasee S Moorthy

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

WHO RSV Vaccine Consultation Expert Group

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Kayvon Modjarrad

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

language of work or name

0 references

publication date

20 June 2015

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

34

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

190-197

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

The histopathology of fatal untreated human respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

A role for immune complexes in enhanced respiratory syncytial virus disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

Current concepts and progress in RSV vaccine development.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

The path to an RSV vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

The influence of placental malaria infection and maternal hypergammaglobulinemia on transplacental transfer of antibodies and IgG subclasses in a rural West African population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

Refining the balance of attenuation and immunogenicity of respiratory syncytial virus by targeted codon deoptimization of virulence genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

Latitudinal variations in seasonal activity of influenza and respiratory syncytial virus (RSV): a global comparative review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

Respiratory syncytial virus circulation in seven countries with Global Disease Detection Regional Centers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

Prolonged seasonality of respiratory syncytial virus infection among preterm infants in a subtropical climate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

International variation in the management of infants hospitalized with respiratory syncytial virus. International RSV Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

Incidence and severity of respiratory syncytial virus pneumonia in rural Kenyan children identified through hospital surveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

The source of respiratory syncytial virus infection in infants: a household cohort study in rural Kenya

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

Phase-I study MEDI-534, of a live, attenuated intranasal vaccine against respiratory syncytial virus and parainfluenza-3 virus in seropositive children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

Phase 1 study of the safety and immunogenicity of a live, attenuated respiratory syncytial virus and parainfluenza virus type 3 vaccine in seronegative children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.093

7 January 2021

Vaccines for preventing rotavirus diarrhoea: vaccines in use

1 reference

https://pubmed.ncbi.nlm.nih.gov/26100926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between respiratory syncytial virus hospitalizations in infants and respiratory sequelae: systematic review and meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26100926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Respiratory syncytial virus infection: denominator-based studies in Indonesia, Mozambique, Nigeria and South Africa

1 reference

https://pubmed.ncbi.nlm.nih.gov/26100926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bovine model of respiratory syncytial virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/26100926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/26100926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Live-attenuated respiratory syncytial virus vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/26100926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/26100926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.VACCINE.2015.05.093

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45341636&oldid=1446460956"